 
  | Statistics for thread Replaying your death from the perspective of the killer | |
| General statistics | |
| Total posts | 22 | 
| First post | 2014-08-01 20:07:00 | 
| Last post | 2014-08-03 06:47:00 | 
| Duration | 2 days (active period), 4072 days (since first post) | 
| Daily average | 11,0 posts/day (active period), 0,0 posts/day (since first post) | 
| Typed characters | 9 962 | 
| Longest post | Apothecary Za'ki (2262 characters, posted 2014-08-02 21:12:00) | 
| Average post length | 452,8 chars/post | 
| Unique authors | 17 | 
| 90-day posting graph | |
| Top 50 posters in thread | Posts (% of total) | 
| Apothecary Za'ki | 4 (18,2%) | 
| Dreis Shadowweaver | 2 (9,1%) | 
| Maken Tosch | 2 (9,1%) | 
| Alena Ventrallis | 1 (4,5%) | 
| 501st Headstrong | 1 (4,5%) | 
| Zindorak | 1 (4,5%) | 
| TheEnd762 | 1 (4,5%) | 
| shaman oga | 1 (4,5%) | 
| Mobius Kaethis | 1 (4,5%) | 
| Louis Domi | 1 (4,5%) | 
| Killer's Coys | 1 (4,5%) | 
| Guybrush Threeps | 1 (4,5%) | 
| Gavr1lo Pr1nc1p | 1 (4,5%) | 
| DJINN Jecture | 1 (4,5%) | 
| Bormir1r | 1 (4,5%) | 
| BLOOD Ruler | 1 (4,5%) | 
| Arkena Wyrnspire | 1 (4,5%) | 
| Top 25 alliance posters in thread | Posts (% of total) | 
| - | 11 (50,0%) | 
| General Tso's Alliance | 5 (22,7%) | 
| D.E.F.I.A.N.C.E | 2 (9,1%) | 
| Ivy League | 2 (9,1%) | 
| Dark Taboo | 1 (4,5%) | 
| Proficiency V. | 1 (4,5%) | 
| Top 25 corporation posters in thread | Posts (% of total) | 
| Biomass Positive | 4 (18,2%) | 
| Fatal Absolution | 3 (13,6%) | 
| D.A.R.K L.E.G.I.O.N | 2 (9,1%) | 
| DUST University | 2 (9,1%) | 
| 1.U.P | 1 (4,5%) | 
| BurgezzE.T.F | 1 (4,5%) | 
| G0DS AM0NG MEN | 1 (4,5%) | 
| K-A-O-S theory | 1 (4,5%) | 
| Molon Labe. | 1 (4,5%) | 
| Nexus Balusa Horizon | 1 (4,5%) | 
| Pradox One | 1 (4,5%) | 
| Prima Gallicus | 1 (4,5%) | 
| S0VER31GN | 1 (4,5%) | 
| SVER True Blood | 1 (4,5%) | 
| The Lionheart Coalition | 1 (4,5%) | 
| Copyright © 2013-2025, Chribba - OMG Labs. All Rights Reserved. - perf 0,06s, ref 20250924/0736 EVE-Online™/DUST514™ and EVE/DUST514 imagery © CCP. |